Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, et al. Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer. Breast Cancer Res 2024;26:46.
PMID: 38481291